nach oben

Critical Care

Erschienen in:

01.08.2012 | Viewpoint

Vitamin D in sepsis: from basic science to clinical impact

verfasst von: Jordan A Kempker, Vin Tangpricha, Thomas R Ziegler, Greg S Martin

Erschienen in: Critical Care | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

The growing basic and clinical investigations into the extraskeletal effects of vitamin D have revealed roles in the functioning of the immune system, generating interesting questions about this nutrient's connections to sepsis. This article briefly reviews the current science of the function of vitamin D in the immune system as well as the emerging clinical literature regarding its associations with respiratory infections, sepsis, and critical illness. Finally, we offer views on the potential future directions for research in the field by outlining potential relevant scenarios and outcomes.

Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R, Mader S, White JH: Largescale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005, 19: 2685-2695. 10.1210/me.2005-0106.PubMedCrossRef

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011, 96: 1911-1930. 10.1210/jc.2011-0385.PubMedCrossRef

Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V: Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract. 2009, 15: 438-449. 10.4158/EP09101.ORR.PubMedPubMedCentralCrossRef

Sokol SI, Tsang P, Aggarwal V, Melamed ML, Srinivas VS: Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev. 2011, 19: 192-201. 10.1097/CRD.0b013e31821da9a5.PubMedCrossRef

Zhao G, Ford ES, Li C, Croft JB: Serum 25-hydroxyvitamin D levels and allcause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens. 2012, 30: 284-289. 10.1097/HJH.0b013e32834e1f0a.PubMedCrossRef

Ross AC, Taylor CL, Yaktine AL, Del Valle HB: Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Institute of Medicine Dietary Reference Intakes for Calcium and Vitamin D. 2011, Washington, DC: National Academies Press

Lucidarme O, Messai E, Mazzoni T, Arcade M, du Cheyron D: Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study. Intensive Care Med. 2010, 36: 1609-1611. 10.1007/s00134-010-1875-8.PubMedCrossRef

McKinney JD, Bailey BA, Garrett LH, Peiris P, Manning T, Peiris AN: Relationship between vitamin D status and ICU outcomes in veterans. J Am Med Dir Assoc. 2011, 12: 208-211. 10.1016/j.jamda.2010.04.004.PubMedCrossRef

Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, Tangpricha V: Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med. 2009, 7: 28-10.1186/1479-5876-7-28.PubMedPubMedCentralCrossRef

10.

Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C: Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010, 10: 482-496. 10.1016/j.coph.2010.04.001.PubMedCrossRef

11.

Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zügel U, Steinmeyer A, Pollak A, Roth E, Boltz-Nitulescu G, Spittler A: Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006, 36: 361-370. 10.1002/eji.200425995.PubMedCrossRef

12.

Equils O, Naiki Y, Shapiro AM, Michelsen K, Lu D, Adams J, Jordan S: 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol. 2006, 143: 58-64. 10.1111/j.1365-2249.2005.02961.x.PubMedPubMedCentralCrossRef

13.

Horiuchi H, Nagata I, Komoriya K: Protective effect of vitamin D3 analogues on endotoxin shock in mice. Agents Actions. 1991, 33: 343-348. 10.1007/BF01986584.PubMedCrossRef

14.

Asakura H, Aoshima K, Suga Y, Yamazaki M, Morishita E, Saito M, Miyamoto K, Nakao S: Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models. Thromb Haemost. 2001, 85: 287-290.PubMed

15.

Moller S, Laigaard F, Olgaard K, Hemmingsen C: Effect of 1,25-dihydroxyvitamin D3 in experimental sepsis. Int J Med Sci. 2007, 4: 190-195.PubMedPubMedCentralCrossRef

16.

Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW, Goleva E: Vitamin d inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012, 188: 2127-2135. 10.4049/jimmunol.1102412.PubMedPubMedCentralCrossRef

17.

Khoo AL, Chai LY, Koenen HJ, Kullberg BJ, Joosten I, van der Ven AJ, Netea MG: 1,25-dihydroxyvitamin D3 modulates cytokine production induced by Candida albicans: impact of seasonal variation of immune responses. J Infect Dis. 2011, 203: 122-130. 10.1093/infdis/jiq008.PubMedPubMedCentralCrossRef

18.

Nelson CD, Reinhardt TA, Beitz DC, Lippolis JD: In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection. PLoS One. 2010, 5: e15469-10.1371/journal.pone.0015469.PubMedPubMedCentralCrossRef

19.

Hewison M: Antibacterial effects of vitamin D. Nat Rev Endocrinol. 2011, 7: 436-CrossRef

20.

Kamen DL, Tangpricha V: Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl). 2010, 88: 441-450. 10.1007/s00109-010-0590-9.CrossRef

21.

Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006, 311: 1770-1773. 10.1126/science.1123933.PubMedCrossRef

22.

Nijnik A, Hancock RE: The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol. 2009, 16: 41-47. 10.1097/MOH.0b013e32831ac517.PubMedCrossRef

23.

Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G: Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J Cyst Fibros. 2007, 6: 403-410. 10.1016/j.jcf.2007.03.003.PubMedPubMedCentralCrossRef

24.

Hertting O, Holm A, Luthje P, Brauner H, Dyrdak R, Jonasson AF, Wiklund P, Chromek M, Brauner A: Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder. PLoS One. 2010, 5: e15580-10.1371/journal.pone.0015580.PubMedPubMedCentralCrossRef

25.

Hodgin KE, Moss M: The epidemiology of sepsis. Curr Pharm Des. 2008, 14: 1833-1839. 10.2174/138161208784980590.PubMedCrossRef

26.

Ginde AA, Mansbach JM, Camargo CA: Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009, 169: 384-390. 10.1001/archinternmed.2008.560.PubMedPubMedCentralCrossRef

27.

Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML: Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 2010, 5: e11088-10.1371/journal.pone.0011088.PubMedPubMedCentralCrossRef

28.

Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamaki H: Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis. 2010, 202: 809-814. 10.1086/654881.PubMedCrossRef

29.

Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, Berbari N: A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect. 2009, 137: 1396-1404. 10.1017/S0950268809002404.PubMedCrossRef

30.

Wayse V, Yousafzai A, Mogale K, Filteau S: Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur J Clin Nutr. 2004, 58: 563-567. 10.1038/sj.ejcn.1601845.PubMedCrossRef

31.

Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A: Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2009, 63: 473-477. 10.1038/sj.ejcn.1602960.PubMedCrossRef

32.

Roth DE, Shah R, Black RE, Baqui AH: Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatr. 2010, 99: 389-393. 10.1111/j.1651-2227.2009.01594.x.PubMedCrossRef

33.

Roth DE, Jones AB, Prosser C, Robinson JL, Vohra S: Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in early childhood. Eur J Clin Nutr. 2009, 63: 297-299. 10.1038/sj.ejcn.1602946.PubMedCrossRef

34.

McNally JD, Leis K, Matheson LA, Karuananyake C, Sankaran K, Rosenberg AM: Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr Pulmonol. 2009, 44: 981-988. 10.1002/ppul.21089.PubMedCrossRef

35.

Manaseki-Holland S, Qader G, Isaq Masher M, Bruce J, Zulf Mughal M, Chandramohan D, Walraven G: Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health. 2010, 15: 1148-1155. 10.1111/j.1365-3156.2010.02578.x.PubMedCrossRef

36.

Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H: Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010, 91: 1255-1260. 10.3945/ajcn.2009.29094.PubMedCrossRef

37.

Lee P, Eisman JA, Center JR: Vitamin D deficiency in critically ill patients. N Engl J Med. 2009, 360: 1912-1914. 10.1056/NEJMc0809996.PubMedCrossRef

38.

Pittas AG, Dawson-Hughes B: Vitamin D and diabetes. J Steroid Biochem Mol Biol. 2010, 121: 425-429. 10.1016/j.jsbmb.2010.03.042.PubMedPubMedCentralCrossRef

39.

Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R: Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003, 88: 4623-4632. 10.1210/jc.2003-030358.PubMedCrossRef

40.

Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008, 168: 1629-1637. 10.1001/archinte.168.15.1629.PubMedPubMedCentralCrossRef

41.

Finklea JD, Grossmann RE, Tangpricha V: Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies. Adv Nutr. 2011, 2: 244-253.PubMedPubMedCentralCrossRef

42.

Amrein K, Venkatesh B: Vitamin D and the critically ill patient. Curr Opin Clin Nutr Metab Care. 2012, 15: 188-193. 10.1097/MCO.0b013e32834f0027.PubMedCrossRef

43.

Braun A, Chang D, Mahadevappa K, Gibbons FK, Liu Y, Giovannucci E, Christopher KB: Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit Care Med. 2011, 39: 671-677. 10.1097/CCM.0b013e318206ccdf.PubMedPubMedCentralCrossRef

44.

Braun AB, Gibbons FK, Litonjua AA, Giovannucci E, Christopher KB: Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med. 2012, 40: 63-72. 10.1097/CCM.0b013e31822d74f3.PubMedPubMedCentralCrossRef

45.

Venkatram S, Chilimuri S, Adrish M, Salako A, Patel M, Diaz-Fuentes G: Vitamin D deficiency as associated with mortality in the medical intensive care unit. Crit Care. 2011, 15: R292-10.1186/cc10585.PubMedPubMedCentralCrossRef

46.

Flynn L, Zimmerman LH, McNorton K, Dolman M, Tyburski J, Baylor A, Wilson R, Dolman H: Effects of vitamin D deficiency in critically ill surgical patients. Am J Surg. 2012, 203: 379-382. 10.1016/j.amjsurg.2011.09.012.PubMedCrossRef

47.

Cecchi A, Bonizzoli M, Douar S, Mangini M, Paladini S, Gazzini B, Degl'innocenti S, Linden M, Zagli G, Peris A: Vitamin D deficiency in septic patients at ICU admission is not a mortality predictor. Minerva Anestesiol. 2011, 77: 1184-1189.PubMed

48.

Ginde AA, Camargo CA, Shapiro NI: Vitamin D insufficiency and sepsis severity in emergency department patients with suspected infection. Acad Emerg Med. 2011, 18: 551-554. 10.1111/j.1553-2712.2011.01047.x.PubMedCrossRef

49.

Bjelakovic G, Gluud LL, Nikolova D, Bjelakovic M, Nagorni A, Gluud C: Meta-analysis: antioxidant supplements for liver diseases - the Cochrane Hepato-Biliary Group. Aliment Pharmacol Ther. 2010, 32: 356-367. 10.1111/j.1365-2036.2010.04371.x.PubMedCrossRef

50.

Krishnan A, Ochola J, Mundy J, Jones M, Kruger P, Duncan E, Venkatesh B: Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Crit Care. 2010, 14: R216-10.1186/cc9341.PubMedPubMedCentralCrossRef

51.

Kouroumichakis I, Papanas N, Proikaki S, Zarogoulidis P, Maltezos E: Statins in prevention and treatment of severe sepsis and septic shock. Eur J Intern Med. 2011, 22: 125-133. 10.1016/j.ejim.2010.12.004.PubMedCrossRef

52.

Yavuz B, Ertugrul DT, Cil H, Ata N, Akin KO, Yalcin AA, Kucukazman M, Dal K, Hokkaomeroglu MS, Yavuz BB, Tutal E: Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?. Cardiovasc Drugs Ther. 2009, 23: 295-299. 10.1007/s10557-009-6181-8.PubMedCrossRef

53.

Perez-Castrillon JL, Vega G, Abad L, Sanz A, Chaves J, Hernandez G, Duenas A: Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol. 2007, 99: 903-905. 10.1016/j.amjcard.2006.11.036.PubMedCrossRef

54.

Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348: 1546-1554. 10.1056/NEJMoa022139.PubMedCrossRef

55.

Barnato AE, Alexander SL, Linde-Zwirble WT, Angus DC: Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med. 2008, 177: 279-284.PubMedPubMedCentralCrossRef

56.

Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS: The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med. 2006, 34: 2576-2582. 10.1097/01.CCM.0000239114.50519.0E.PubMedPubMedCentralCrossRef

57.

Mayr FB, Yende S, Linde-Zwirble WT, Peck-Palmer OM, Barnato AE, Weissfeld LA, Angus DC: Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA. 2010, 303: 2495-2503. 10.1001/jama.2010.851.PubMedPubMedCentralCrossRef

58.

Grant WB, Peiris AN: Possible role of serum 25-hydroxyvitamin D in blackwhite health disparities in the United States. J Am Med Dir Assoc. 2010, 11: 617-628. 10.1016/j.jamda.2010.03.013.PubMedCrossRef

59.

Chen TC, Chimeh F, Lu Z, Mathieu J, Person KS, Zhang A, Kohn N, Martinello S, Berkowitz R, Holick MF: Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys. 2007, 460: 213-217. 10.1016/j.abb.2006.12.017.PubMedPubMedCentralCrossRef

60.

Danai PA, Sinha S, Moss M, Haber MJ, Martin GS: Seasonal variation in the epidemiology of sepsis. Crit Care Med. 2007, 35: 410-415. 10.1097/01.CCM.0000253405.17038.43.PubMedCrossRef

61.

Maxwell JD: Seasonal variation in vitamin D. Proc Nutr Soc. 1994, 53: 533-543. 10.1079/PNS19940063.PubMedCrossRef

62.

Bischof MG, Heinze G, Vierhapper H: Vitamin D status and its relation to age and body mass index. Horm Res. 2006, 66: 211-215. 10.1159/000094932.PubMedCrossRef

63.

Amrein K, Sourij H, Wagner G, Holl A, Pieber TR, Smolle KH, Stojakovic T, Schnedl C, Dobnig H: Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Crit Care. 2011, 15: R104-10.1186/cc10120.PubMedPubMedCentralCrossRef

64.

Mata-Granados JM, Vargas-Vasserot J, Ferreiro-Vera C, Luque de Castro MD, Pavón RG, Quesada Gómez JM: Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LC-MS/MS method. J Steroid Biochem Mol Biol. 2010, 121: 452-455. 10.1016/j.jsbmb.2010.03.078.PubMedCrossRef

Titel: Vitamin D in sepsis: from basic science to clinical impact
verfasst von: Jordan A Kempker
Vin Tangpricha
Thomas R Ziegler
Greg S Martin
Publikationsdatum: 01.08.2012
Verlag: BioMed Central
Erschienen in: Critical Care / Ausgabe 4/2012
Elektronische ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc11252

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Vitamin D in sepsis: from basic science to clinical impact

Abstract

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

The effect of telemedicine in critically ill patients: systematic review and meta-analysis

Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy

One more idea on preventable ICU deaths ...

Alkaline phosphatase activity after cardiothoracic surgery in infants and correlation with post-operative support and inflammation: a prospective cohort study

Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study

Prognostic utility and characterization of cell-free DNA in patients with severe sepsis

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS